{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:24Z","timestamp":1786985784631,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.cca.2014.01.012","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T08:15:44Z","timestamp":1391674544000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Interleukin-17A in lipid metabolism and atherosclerosis"],"prefix":"10.1016","volume":"431","author":[{"given":"Xiao-Hua","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5058-7087","authenticated-orcid":false,"given":"Francisco S.","family":"Cayabyab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Bin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.01.012_bb0005","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20110496","article-title":"IL-17\/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential","volume":"122","author":"Zhu","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cca.2014.01.012_bb0010","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1631\/jzus.BQICC701","article-title":"Interleukin-17 and acute coronary syndrome","volume":"14","author":"Su","year":"2013","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.cca.2014.01.012_bb0015","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/jimmunol.177.1.36","article-title":"Cutting edge: interleukin 17 signals through a heteromeric receptor complex","volume":"177","author":"Toy","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0025","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni.1813","article-title":"Structural basis of receptor sharing by interleukin 17 cytokines","volume":"10","author":"Ely","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0030","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/ncomms2880","article-title":"Crystal structures of interleukin 17A and its complex with IL-17 receptor A","volume":"4","author":"Liu","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.cca.2014.01.012_bb0035","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/j.1365-2222.2012.04060.x","article-title":"Human eosinophils release IL-1ss and increase expression of IL-17A in activated CD4+ T lymphocytes","volume":"42","author":"Esnault","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.cca.2014.01.012_bb0040","first-page":"1375","article-title":"Pathologic finding of increased expression of interleukin-17 in the synovial tissue of rheumatoid arthritis patients","volume":"6","author":"Li","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.cca.2014.01.012_bb0045","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4049\/jimmunol.1201010","article-title":"Induced IL-17-producing invariant NKT cells require activation in presence of TGF-beta and IL-1beta","volume":"190","author":"Monteiro","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0050","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0055","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.4049\/jimmunol.1201797","article-title":"The beta-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22","volume":"189","author":"Lilly","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0060","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/ibd.21476","article-title":"IRF4 regulates IL-17A promoter activity and controls RORgammat-dependent Th17 colitis in vivo","volume":"17","author":"Mudter","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cca.2014.01.012_bb0065","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ni.1798","article-title":"MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis","volume":"10","author":"Du","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0070","doi-asserted-by":"crossref","first-page":"e46082","DOI":"10.1371\/journal.pone.0046082","article-title":"MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2014.01.012_bb0075","first-page":"171","article-title":"beta-arrestin2 stimulates interleukin-17 production and expression of CD4+ T lymphocytes in a murine asthma model","volume":"10","author":"Liu","year":"2011","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0080","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.4049\/jimmunol.1301079","article-title":"Cholera toxin directly enhances IL-17A production from human CD4+ T cells","volume":"191","author":"Tsai","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0380","doi-asserted-by":"crossref","first-page":"ra83","DOI":"10.1126\/scisignal.2004214","article-title":"The Transcription Factor CREB Enhances Interleukin-17A Production and Inflammation in a Mouse Model of Atherosclerosis","volume":"6","author":"Kotla","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.cca.2014.01.012_bb0090","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar4326","article-title":"Interferon alpha inhibits antigen-specific production of proinflammatory cytokines and enhances antigen-specific transforming growth factor beta production in antigen-induced arthritis","volume":"15","author":"Chalise","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2014.01.012_bb0095","doi-asserted-by":"crossref","DOI":"10.1902\/jop.2013.130132","article-title":"Oral Administration of All-Trans Retinoic Acid Suppresses Experimental Periodontitis by Modulating the Th17\/Treg Imbalance","author":"Wang","year":"2013","journal-title":"J Periodontol"},{"key":"10.1016\/j.cca.2014.01.012_bb0100","doi-asserted-by":"crossref","first-page":"e67078","DOI":"10.1371\/journal.pone.0067078","article-title":"Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2014.01.012_bb0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4149\/gpb_2013043","article-title":"Increased production of IL-6 and IL-17 in lipopolysaccharide-stimulated peripheral mononuclears from patients with rheumatoid arthritis","volume":"32","author":"Chovanova","year":"2013","journal-title":"Gen Physiol Biophys"},{"key":"10.1016\/j.cca.2014.01.012_bb0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11596-013-1145-4","article-title":"Dexamethasone reduces IL-17 and Tim-3 expression in BALF of asthmatic mice","volume":"33","author":"Lu","year":"2013","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.cca.2014.01.012_bb0115","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ajpath.2013.01.005","article-title":"Regulation of IL-17 family members by adrenal hormones during experimental sepsis in mice","volume":"182","author":"Bosmann","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cca.2014.01.012_bb0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2012.12.003","article-title":"Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis","volume":"256","author":"Unoda","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4049\/jimmunol.1200868","article-title":"Early growth response gene-2 controls IL-17 expression and Th17 differentiation by negatively regulating Batf","volume":"190","author":"Miao","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.febslet.2011.11.021","article-title":"Tristetraprolin down-regulates IL-17 through mRNA destabilization","volume":"586","author":"Lee","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cca.2014.01.012_bb0135","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cyto.2013.01.009","article-title":"Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis","volume":"61","author":"Blalock","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2014.01.012_bb0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.taap.2012.05.004","article-title":"Inorganic arsenic represses interleukin-17A expression in human activated Th17 lymphocytes","volume":"262","author":"Morzadec","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.cca.2014.01.012_bb0145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cyto.2013.07.022","article-title":"IL-17 family: Cytokines, receptors and signaling","volume":"64","author":"Gu","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2014.01.012_bb0150","doi-asserted-by":"crossref","first-page":"35603","DOI":"10.1074\/jbc.C600256200","article-title":"Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor","volume":"281","author":"Chang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2014.01.012_bb0155","doi-asserted-by":"crossref","first-page":"ra63","DOI":"10.1126\/scisignal.2000382","article-title":"Act1, a U-box E3 ubiquitin ligase for IL-17 signaling","volume":"2","author":"Liu","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.cca.2014.01.012_bb0160","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm.2815","article-title":"The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha","volume":"18","author":"Zhu","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2014.01.012_bb0165","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10529-010-0440-4","article-title":"IL-17A promotes transdifferentiation of mouse myoblast cells (C2C12) into adipocytes by increasing the expression of peroxisome proliferator-activated receptor gamma through CAAT\/enhancer binding protein beta signaling","volume":"33","author":"Lee","year":"2011","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.cca.2014.01.012_bb0170","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.4049\/jimmunol.1003447","article-title":"Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding","volume":"186","author":"Zhang","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0175","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.4049\/jimmunol.179.6.4135","article-title":"IL-17 enhances chemokine gene expression through mRNA stabilization","volume":"179","author":"Hartupee","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0180","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ni.2080","article-title":"The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation","volume":"12","author":"Bulek","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0185","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/ni.2081","article-title":"Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)","volume":"12","author":"Sun","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0190","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4049\/jimmunol.1203315","article-title":"HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization","volume":"191","author":"Herjan","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0195","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1128\/MCB.00268-12","article-title":"TRAF6-dependent Act1 phosphorylation by the IkappaB kinase-related kinases suppresses interleukin-17-induced NF-kappaB activation","volume":"32","author":"Qu","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cca.2014.01.012_bb0200","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ni.2427","article-title":"Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25","volume":"13","author":"Zhong","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0205","doi-asserted-by":"crossref","first-page":"ra44","DOI":"10.1126\/scisignal.2003699","article-title":"The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling","volume":"6","author":"Garg","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.cca.2014.01.012_bb0210","doi-asserted-by":"crossref","first-page":"e70168","DOI":"10.1371\/journal.pone.0070168","article-title":"The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction","volume":"8","author":"Ho","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2014.01.012_bb0215","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1084\/jem.20100703","article-title":"Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling","volume":"207","author":"Zhu","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.cca.2014.01.012_bb0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4049\/jimmunol.1200470","article-title":"Cutting edge: TNF receptor-associated factor 4 restricts IL-17-mediated pathology and signaling processes","volume":"189","author":"Zepp","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0225","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ni.2479","article-title":"The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90","volume":"14","author":"Wang","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0230","doi-asserted-by":"crossref","first-page":"ra73","DOI":"10.1126\/scisignal.2001653","article-title":"Persistent stimulation with interleukin-17 desensitizes cells through SCFbeta-TrCP-mediated degradation of Act1","volume":"4","author":"Shi","year":"2011","journal-title":"Sci Signal"},{"key":"10.1016\/j.cca.2014.01.012_bb0235","doi-asserted-by":"crossref","first-page":"ra8","DOI":"10.1126\/scisignal.2000066","article-title":"IL-17 receptor signaling inhibits C\/EBPbeta by sequential phosphorylation of the regulatory 2 domain","volume":"2","author":"Shen","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.cca.2014.01.012_bb0240","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","article-title":"Foam cells in atherosclerosis","volume":"424","author":"Yu","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.01.012_bb0245","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2119\/molmed.2011.00183","article-title":"The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids","volume":"18","author":"Zhao","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.cca.2014.01.012_bb0250","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/iub.1165","article-title":"ATP-binding cassette transporters and cholesterol translocation","volume":"65","author":"Li","year":"2013","journal-title":"IUBMB Life"},{"key":"10.1016\/j.cca.2014.01.012_bb0255","doi-asserted-by":"crossref","first-page":"e73861","DOI":"10.1371\/journal.pone.0073861","article-title":"LDL Cholesterol Modulates Human CD34+ HSPCs through Effects on Proliferation and the IL-17G-CSF Axis","volume":"8","author":"Cimato","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2014.01.012_bb0260","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1253\/circj.CJ-11-1338","article-title":"Interleukin-18 and Interleukin-12 Together Downregulate ATP-Binding Cassette Transporter A1 Expression Through the Interleukin-18R\/Nuclear Factor-kappaB Signaling Pathway in THP-1 Macrophage-Derived Foam Cells","volume":"76","author":"Yu","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.cca.2014.01.012_bb0265","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.atherosclerosis.2008.07.029","article-title":"IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK\/STAT signaling pathway-dependent manner","volume":"203","author":"Hao","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2014.01.012_bb0270","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/ejh.12074","article-title":"Interleukin-17 enhances the production of interferon-gamma and tumour necrosis factor-alpha by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes","volume":"90","author":"Zhang","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cca.2014.01.012_bb0275","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.4049\/jimmunol.1001879","article-title":"IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice","volume":"185","author":"Chen","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physrev.00002.2012","article-title":"Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis","volume":"93","author":"Bohdanowicz","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cca.2014.01.012_bb0285","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cyto.2013.05.016","article-title":"Differential regulation of macropinocytosis in macrophages by cytokines: Implications for foam cell formation and atherosclerosis","volume":"64","author":"Michael","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2014.01.012_bb0290","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-511X-12-123","article-title":"Ethanolic extract of propolis inhibits atherosclerosis in ApoE-knockout mice","volume":"12","author":"Fang","year":"2013","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.cca.2014.01.012_bb0295","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/ATVBAHA.111.229997","article-title":"Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice","volume":"32","author":"Danzaki","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2014.01.012_bb0300","doi-asserted-by":"crossref","first-page":"196ra100","DOI":"10.1126\/scitranslmed.3006133","article-title":"Transforming Growth Factor-beta Signaling in T Cells Promotes Stabilization of Atherosclerotic Plaques Through an Interleukin-17-Dependent Pathway","volume":"5","author":"Gistera","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cca.2014.01.012_bb0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00395-010-0135-y","article-title":"Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability","volume":"106","author":"Erbel","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cca.2014.01.012_bb0310","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2011.12.026","article-title":"Correlation of peripheral Th17 cells and Th17-associated cytokines to the severity of carotid artery plaque and its clinical implication","volume":"221","author":"Liu","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2014.01.012_bb0315","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cca.2010.10.027","article-title":"Interleukin-17A gene variants and risk of coronary artery disease: a large angiography-based study","volume":"412","author":"Zhang","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.01.012_bb0320","first-page":"e87","article-title":"Interleukin 17A exacerbates atherosclerosis by promoting fatty acid-binding protein 4-mediated ER stress in macrophages","volume":"112","author":"Gao","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2014.01.012_bb0325","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clim.2011.07.003","article-title":"IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome","volume":"141","author":"Zhu","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cca.2014.01.012_bb0330","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2012.02.117","article-title":"Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice","volume":"420","author":"Usui","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2014.01.012_bb0335","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","article-title":"Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.01.012_bb0340","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCRESAHA.111.261784","article-title":"The IL-17A\/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment","volume":"110","author":"Butcher","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2014.01.012_bb0345","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/CIRCRESAHA.113.301934","article-title":"Increased Atherosclerotic Lesion Formation and Vascular Leukocyte Accumulation in Renal Impairment are Mediated by Interleukin 17A","volume":"113","author":"Ge","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2014.01.012_bb0350","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2009.07.152","article-title":"Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice","volume":"388","author":"van Es","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2014.01.012_bb0355","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.atherosclerosis.2010.12.034","article-title":"Inhibition of IL-17A in atherosclerosis","volume":"215","author":"Cheng","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2014.01.012_bb0360","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1161\/ATVBAHA.111.227629","article-title":"Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice","volume":"31","author":"Madhur","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2014.01.012_bb0365","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2014.01.012_bb0370","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2014.01.012_bb0375","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1038\/jid.2012.163","article-title":"Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial","volume":"132","author":"Papp","year":"2012","journal-title":"J Invest Dermatol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T07:03:18Z","timestamp":1565161398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":75,"alternative-id":["S0009898114000291"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.01.012","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-17A in lipid metabolism and atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}